Navigation Links
Horizon Therapeutics Names Robert J. De Vaere Executive Vice President and Chief Financial Officer
Date:10/9/2008

SKOKIE, Ill., Oct. 9 /PRNewswire/ -- Horizon Therapeutics, Inc., a privately held biopharmaceutical company, announced today that Robert J. De Vaere has joined the Company as executive vice president and chief financial officer.

"Bob is an experienced executive who brings more than 28 years of financial management experience to Horizon, including the last decade in healthcare with both public and private companies," said Timothy P. Walbert, president and chief executive officer. "During his career, Bob has been instrumental in numerous M&A transactions as well as an IPO and will be an important part of Horizon's future growth."

Mr. De Vaere's most recent position was as senior vice president, finance and administration and chief financial officer of IDM Pharma, Inc. (Nasdaq: IDMI), a biopharmaceutical company focused on the development of innovative products that activate the immune system to treat cancer. Additionally, Mr. De Vaere served as vice president, finance and administration and chief financial officer of IDM Pharma from August 2005 to March 2006, and was vice president and chief financial officer of Epimmune from May 2000 until the business combination with IDM Pharma in August 2005.

Mr. De Vaere has also served as chief financial officer of Nexa Orthopedics, which was acquired by Tornier, Inc. and vice president of finance and administration and chief financial office of Vista Medical Technologies, Inc., a medical device company.

Earlier in his career, Mr. De Vaere held accounting, finance and administrative positions within the electronics and aerospace industries. Mr. De Vaere received a bachelor's degree from the University of California, Los Angeles.

About Horizon Therapeutics

Hori
'/>"/>

SOURCE Horizon Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Out beyond the horizon
2. Out beyond the horizon
3. BioHorizons Announces Agreement to Purchase Implant Logic Systems
4. Biotech Pioneer William J. Rutter to Deliver Keynote at 2008 RAPS Horizons Conference
5. Caliper Life Sciences Forms Alliance With Horizon Discovery to Provide Enhanced Solutions for Cancer Research Based on Isogenic Cell Lines
6. BioHorizons Announces the Purchase of Implant Logic Systems
7. BioHorizons Global Symposium 2008 Combines Record Attendance with Groundbreaking Technology
8. Horizon Therapeutics Announces Corporate Relocation to the Chicago Area
9. Horizon Therapeutics to Present at UBS Global Life Sciences Conference
10. Horizon Therapeutics to Present at JMP Securities Healthcare Focus Conference
11. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... , SAN FRANCISCO, Dec. 1 /PRNewswire-FirstCall/...rd: MZEI) announced today that in tests involving ...tinues to break "6 log" decontamination barriers, ...cteria, Claustridium difficile and Bacillis subtil...) as an extremely potent sporicidal technology. "T...
(Date:12/1/2009)... The two humanitarian organizati...grams, including biomedical repair technologies. T...the West African country of Togo. , ...With the recent signing of a Memorandum of Underst...e formalized a partnership to help develop sustain...
(Date:11/30/2009)...bridge, Mass November 30, 2009 An international ... Photonics, and ETH Zrich have demonstrated compac... in the invisible part of the light spectrum (infr...ight beam of a well-defined wavelength. The innova...ations related to remote chemical sensing pollutio...
(Date:11/30/2009)... , BRIARCLIFF MANOR, N.Y., Nov. 30 /PRNews... guidance document for the publication of company-...ine today by the British Medical Journal (BMJ). "T...n of the importance of providing support and guida...ation of study results in the peer-reviewed medica...
Breaking Biology Technology:Medizone International Takes Aim at the Bioterrorism Countermeasures Arena 2Mercy Ships and MediSend International Partner to Deliver Hope and Healing 2Mercy Ships and MediSend International Partner to Deliver Hope and Healing 3Scientists demonstrate multibeam, multi-functional lasers 2ISMPP Announces Publication of Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP2 Guidelines Published in the BMJ 2ISMPP Announces Publication of Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP2 Guidelines Published in the BMJ 3
...Today, GAITHERSBURG, Md., March 6 Iomai Corporat...lts and corporate progress for,the full year ended...have further demonstrated that Iomai,s,vaccine and...vely,self-applied," said Stanley C. Erck, presiden... the foundation for a revolution in the way vaccin...
...en,Inc. (Pink Sheets: VXGN), a biopharmaceutical c...lts and more recent cash balance, with a view to,e...nancial information,ahead of voting on the company... VaxGen,s Board of Directors has set March 28, 200...ers to vote on the proposed merger., (Logo: ...
...tting With Trellis-8 Catheter From Bacchus Vasc... Complications and Treatment Cost,...nc., a,leading provider of innovative medical devi...surgeons and interventional cardiologists for the,...is (DVT) and other,peripheral vascular disease, an...
Other Biology Technology:Iomai Announces Year-End 2007 Financial Results and Business Progress 2Iomai Announces Year-End 2007 Financial Results and Business Progress 3Iomai Announces Year-End 2007 Financial Results and Business Progress 4Iomai Announces Year-End 2007 Financial Results and Business Progress 5Iomai Announces Year-End 2007 Financial Results and Business Progress 6VaxGen Reports Financial Update 2VaxGen Reports Financial Update 3VaxGen Reports Financial Update 4VaxGen Reports Financial Update 5VaxGen Reports Financial Update 6VaxGen Reports Financial Update 7Major Medical Journal Reports Higher Success, Fewer Complications and Lower Cost Treating DVT With Trellis(R) Isolated Thrombolysis Compared With Catheter-Directed Thrombolysis 2
(Date:11/30/2009)...om LSU Health Sciences Center New Orleans School o...nstitute of Child Health and Human Development (NI... Women,s Hospital, and Harvard Medical School, hav... 5 servings of sugar- sweetened cola a week prior ...risk of developing diabetes during pregnancy. Liwe...
(Date:11/30/2009)... are crucial for infection. Each binds a specific ...ulates the host cell to take up the pathogen. Norm...unction, for example the regulation of cell growth...een published in the current issue of the " Journa...of the sources for Listeria infections leading t...
(Date:11/30/2009)...of seeing your extended family over the holidays w...rt in the December 2009 print issue of the Journa...) shows that you might be right. Here,s the good n...irely new treatments that help keep autoimmune dis...rol. That,s because researchers from the Universit...
Breaking Biology News(10 mins):Sugary cola drinks linked for first time to higher risk of gestational diabetes 2Sugary cola drinks linked for first time to higher risk of gestational diabetes 3It takes 2 to infect 2Seeing family for the holidays? Scientists discover how the stress might kill you 2MessageSolution Enterprise Email Archive Named Top Exchange Archiving Solution by Leading Exchange Site MSExchange org 55476 1MessageSolution Enterprise Email Archive Named Top Exchange Archiving Solution by Leading Exchange Site MSExchange org 55476 2MessageSolution Enterprise Email Archive Named Top Exchange Archiving Solution by Leading Exchange Site MSExchange org 55476 3MessageSolution Enterprise Email Archive Named Top Exchange Archiving Solution by Leading Exchange Site MSExchange org 55476 4MessageSolution Enterprise Email Archive Named Top Exchange Archiving Solution by Leading Exchange Site MSExchange org 55476 5Essilor 3A First Half 2009 Results 55471 1Essilor 3A First Half 2009 Results 55471 2Essilor 3A First Half 2009 Results 55471 3Essilor 3A First Half 2009 Results 55471 4Essilor 3A First Half 2009 Results 55471 5Essilor 3A First Half 2009 Results 55471 6Essilor 3A First Half 2009 Results 55471 7Essilor 3A First Half 2009 Results 55471 8Essilor 3A First Half 2009 Results 55471 9Discovery of natural odors could help develop mosquito repellents 13710 1Discovery of natural odors could help develop mosquito repellents 13710 2Discovery of natural odors could help develop mosquito repellents 13710 3
...rediction, an automatic cameraman, wall boards mad...common sense, origami optics, privacy-preserving s... and stem cell control with nano-science are just ...every corner of the engineering world that will be...ering graduate students on Thursday 21 February 20...
...he U.S. Department of Homeland,Security (DHS) anno...l,fingerprints from international visitors arrivin...ge is part of the department,s upgrade from two-,t...d facilitate legitimate,travel by more accurately ...s, identities., "Biometrics have revolutionized o...
...r most northern indigenous people, the roughly 3 m...nt terrestrial subsistence resource, and while hun...ern about the on-going availability of caribou, th...red. , For years people have managed natural re... have functioned in the past, which assumes condit...
Other Biology News:DHS Begins Collecting 10 Fingerprints From International Visitors at Miami International Airport 2Seeking sustainability in a world of instability 2
CORNING SPIN-X CENTRIFUGE TUBE FILTER,2ML,CA, NON-STERILE,CS=100 from Sigma-Aldrich
...stem provides high-throughput, quantitative gene e... The systems patented priming strategy overcomes ...lysis to just a few genes at a time. GenomeLab Ge...es per run, removing bottlenecks in gene expressio...
...mple high performance method for removing detergen...hout significant dilution of protein solution. Si...T Spin column and collect detergent free protein s...detergents from a 1.0 mL solution of 1.5% Triton-X...
...from Paraffin embedded tissue blocks, which are su...ensure the highest quality. Tissues of each array ...a thickness of 5 microns and mounted on coated sli...mparison to core sections made using Tissue Arraye...
Biology Products: